BioVaxys Technology (TSE:BIOV) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
BioVaxys Technology Corp., a clinical-stage biotech firm, is set to present at the Life Sciences Investor Forum on September 19, 2024, inviting investors and analysts to join the live event online. The company, which specializes in developing therapies for cancers and infectious diseases, will offer opportunities for real-time interaction and scheduled one-on-one meetings with investors.
For further insights into TSE:BIOV stock, check out TipRanks’ Stock Analysis page.
